Amelioration of hepatic steatosis by the androgen receptor inhibitor epi-001 in mice and human hepatic cells is associated with the inhibition of cyp2e1

HIGHLIGHTS

• who: Shuqin Wang and collaborators from the College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China have published the research work: Amelioration of Hepatic Steatosis by the Androgen Receptor Inhibitor EPI-001 in Mice and Human Hepatic Cells Is Associated with the Inhibition of CYP2E1, in the Journal: (JOURNAL)
• what: InInthis study, the authors investigated the the potential of EPI-001 for treating and preventing this study, the authors investigated potential of EPI-001 for treating and preventing NAFLD using human hepatic cell lines and mouse models. The experiment showed that although . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.